Catalogue Number
BN-O1733
Analysis Method
HPLC,NMR,MS
Specification
98%(HPLC)
Storage
-20℃
Molecular Weight
468.8
Appearance
Powder
Botanical Source
This product is isolated and purified from the herbs of Alstonia boonei.
Structure Type
Triterpenoids
Category
Standards;Natural Pytochemical;API
SMILES
CC(=O)OC1CCC2(C(C1(C)C)CCC3(C2CC=C4C3(CCC5(C4CC(CC5)(C)C)C)C)C)C
Synonyms
Olean-12-en-3β-ol, acetate/(3β)-Olean-12-en-3-ylacetat/Acetate de (3β)-olean-12-en-3-yle/(3S,4aR,6aR,6bS,8aR,12aR,14aR,14bR)-4,4,6a,6b,8a,11,11,14b-Octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydro-3-picenyl acetate/Olean-12-en-3-ol, acetate, (3β)-/AMYRIN,B/Olean-12-en-3β-ol, acetate (8CI)/3-β-acetoxyolean-12-ene/O-Acetyl-β-amyrin/(3β)-Olean-12-en-3-yl acetate/β-Amyrin acetate/(3S,4aR,6aR,6bS,8aR,12aR,14aR,14bR)-4,4,6a,6b,8a,11,11,14b-Octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydro-3-picenylacetat/Olean-12-en-3-yl acetate/Acetate de (3S,4aR,6aR,6bS,8aR,12aR,14aR,14bR)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydro-3-picenyle
IUPAC Name
[(3S,4aR,6aR,6bS,8aR,12aR,14aR,14bR)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl] acetate
Density
1.0±0.1 g/cm3
Solubility
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
Flash Point
256.2±17.4 °C
Boiling Point
505.1±49.0 °C at 760 mmHg
Melting Point
InChl
InChl Key
UMRPOGLIBDXFNK-UHFFFAOYSA-N
WGK Germany
RID/ADR
HS Code Reference
2933990000
Personal Projective Equipment
Correct Usage
For Reference Standard and R&D, Not for Human Use Directly.
Meta Tag
provides coniferyl ferulate(CAS#:1616-93-9) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate
No Technical Documents Available For This Product.
22541636
The ethanolic extract and fractions of Wrightia tomentosa Roem. & Schult (Apocynaceae) leaves were tested in vivo for their antidyslipidemic activity in high fat diet (HFD) induced dyslipidemic hamsters. Activity guided isolation resulted in identification of antidyslipidemic compounds β-AA and β-AP. Compounds β-AA and β-AP decrease the levels of LDL by 36% and 44%, and increase the HDL-C/TC ratio by 49% and 28%, respectively, at a dose of 10mg/kg. In addition, the isolated compounds β-AA and β-AP showed significant HMG-CoA-reductase inhibition, which was further established by docking studies.
Copyright © 2012 Elsevier GmbH. All rights reserved.
β-Amyrin acetate and β-amyrin palmitate as antidyslipidemic agents from Wrightia tomentosa leaves.
Maurya R1, Srivastava A, Shah P, Siddiqi MI, Rajendran SM, Puri A, Yadav PP.
2012 Jun 15
18558349
The microbial transformation of beta-amyrin acetate (compound 1) occurred in the culture of Rhodobacter sphaeroides producing three metabolites. The metabolites were purified and identified as beta-amyrin (compound 2), (3beta)-olean-12-ene-3, 23-diol (compound 3), and erythrodiol (compound 4). Initially, it was found that beta-amyrin acetate could be deacetylated and hydroxylated by microbial methods.
Biotransformation of beta-amyrin acetate by Rhodobacter sphaeroides.
2008 May
Description :
Empty ...
